首页 工具
登录
购物车

搜索结果

Search Results for " molm-13 "

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T3184 Kevetrin hydrochloride

Thioureidobutyronitrile HCl,thioureido butyronitrile hydrochloride,4-Isothioureidobutyronitrile hydrochloride

Mdm2; p53 Apoptosis
Kevetrin hydrochloride (4-Isothioureidobutyronitrile hydrochloride) 是一种小分子,是肿瘤抑制蛋白 p53 的激活剂,具有潜在的抗肿瘤活性。
T31221 dBRD9

dBRD-9,dBRD 9

PROTACs PROTAC
dBRD9是一种 PROTAC。dBRD9是一种双重作用的分子,一部分连接 Bromodomain-containing protein 9 (BRD9)的溴域,另一部分招募小脑 E3泛素连接酶的配体(ligand that recruits the cereblon E3 ubiquitin ligase)。dBRD9对 MOLM-13细胞中 BRD9具有抑制作用,可使其降解,IC50为104 nM。
T31221L dBRD9 HCl

dBRD9 HCl(2170679-45-3 Free base)

Epigenetic Reader Domain Chromatin/Epigenetic
dBRD9 HCl 是一种PROTAC,包含cereblon E3连接酶配体与BRD9抑制剂BI 7273。dBRD9 HCl 是有效和选择性的BRD9降解剂,在MOLM-13细胞中IC50的为56.6nM。dBRD9 HCl 在浓度高达5μM 时不会降解BRD4或BRD7。dBRD9 HCl 在人AML 细胞系中显示出抗增殖作用。
T81128 Sontigidomide

Sontigidomide(Compound 5)是一种抗肿瘤化合物,能在1 μM浓度下显著抑制MOLM-13细胞增殖,3天内抑制率超过80%。
T81108 SR-1114

PROTACs PROTAC
SR-1114 是一种创新的PROTACENL降解剂,能够在MV4;11、MOLM-13和OCI/AML-2细胞中迅速降解ENL,其DC50值分别为150 nM 、311 nM 和1.65 μM。
T79596 FLT3-IN-20

FLT3-IN-20(compound 34f)作为一种高效FLT3抑制剂,对FLT3-D835Y和FLT3-ITD具有强效性,IC50值分别仅为1 nM和4 nM。该化合物在携带FLT3-ITD突变的AML细胞系MV4-11和MOLM-13中展现出显著的抗增殖效果,其中IC50值分别为7 nM和9 nM;对于带有FLT3-ITD-D835Y突变的MOLM-13变体,其IC50值为4 nM。FLT3-IN-20主要用于肿瘤治疗研究领域。
T73637 Dot1L-IN-1 TFA

Dot1L-IN-1 TFA 是一种高效选择性Dot1L抑制剂,具有2 pM的Ki值和小于0.1 nM的IC50值。在HeLa细胞中,它能有效抑制H3K79的二甲基化(IC50=3 nM),同时也能在Molm-13细胞中抑制HoxA9启动子的活性(IC50=17 nM)。
T61768 FY-56

FY-56 是一种高效的具有选择性LSD1/KDM1A 抑制剂 (IC50=42 nM),比 MAO-A/B 具有高选择性. FY-56 诱导 MOLM-13 和 MV4-11 细胞分化,具有急性髓系白血病 AML 研究潜力。
T24045 eSM156

eSM 156,eSM-156

eSM156 is an effective FLT3 inhibitor. It has high antiproliferative activity against acute myeloid leukemia (AML) cells. eSM156 has IC50 (FLT3) = 1.4 nM; EC50 (MV4-11cells) = 150 nM; EC50 (MOLM-13 cells) = 40 nM.
T40168 DHODH-IN-16

Dehydrogenase Metabolism
DHODH-IN-16 是一种有效的二氢乳清酸脱氢酶抑制剂(DHODH,IC50 = 0.396 nM)。
T37447 UZH1

UZH1

UZH1 is a racemate of UZH1a and UZH1b. UZH1a is a potent and selective METTL3 inhibitor, with an IC50 of 280 nM. UZH1b (IC50=28 μM) is essentially inactive. UZH1 can be used for epitranscriptomic modulation of cellular processes. UZH1 has antitumor activity. UZH1 also can be used as a chemical probe for studying METTL3[1]. UZH1a (2.5-160 μM; 72 h) inhibits the growth of MOLM-13, HEK293T, and U2Os cells, with IC50s of 11 μM, 67 μM, and 87 μM, respectively[1].UZH1b (2.5-160 μM; 72 h) inhibits the ...
T81806 METTL3-IN-5

METTL3-IN-5(Compound 13)是METTL3抑制剂,对MOLM-13细胞生长的抑制作用显著,其IC50小于2 μM。该化合物对hERG的抑制活性较弱(IC50>30 μM),可应用于AML的研究领域。
T17878 Lenalidomide-C4-NH2 hydrochloride

Cereblon ligand 1 hydrochloride,E3 ligase Ligand-Linker Conjugates 32 hydrochloride

Others Others
Lenalidomide-C4-NH2 hydrochloride is a Cereblon ligand derived from Lenalidomide. It serves as a recruiting agent for the CRBN protein. The compound, known as PROTAC (Compound 24), can be formed by linking Lenalidomide-C4-NH2 hydrochloride to the ligand for the protein. It exhibits inhibitory effects with IC50s of 0.98 nM and 13.7 nM against the growth of RS4;11 and MOLM-13 acute leukemia cell lines, respectively[1].
T69629 M‑89 MLL inhibitor

M‑89 is a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein−Protein Interaction (Kd = 1.4 nM; IC50 = 25nM). M-89 binds to menin with a Kd value of 1.4 nM and effectively engages cellular menin protein at low nanomolar concentrations. M-89 inhibits cell growth in the MV4;11 and MOLM-13 leukemia cell lines carrying MLL fusion with IC50 values of 25 and 55 nM, respectively, and demonstrates >100-fold selectivity over the HL-60 leukemia cell line lacking MLL fusion.
T61005 K783-0308

K783-0308 是有效的、选择性的MNK2和FLT3的双重抑制剂,IC50值分别为 406 和 680nM。 K783-0308 促进急性髓性白血病 (AML)的 细胞凋亡和细胞周期停滞在 G0/G1 期。K783-0308 抑制 MV-4-11 和 MOLM-13 细胞生长,IC50 值分别为 10.4 和 10.5 μM
T62112 CDK8-IN-6

CDK8-IN-6 (compound 9) 是一种细胞周期蛋白依赖性激酶8 (CDK8) 的有效抑制剂 (Kd: 13 nM)。CDK8-IN-6 对 MOLM-13、OCI-AML3、MV4-11、NRK 和 H9c2 细胞表现出细胞毒性,他们 IC50s 分别为 11.2、7.5、8.6、20.5、12.5-25 μM。CDK8-IN-6 对 AML 癌症表现出潜在的研究价值。
T71973 Gilteritinib hemifumarate

ASP2215 hemifumarate

FLT; TAM Receptor Angiogenesis; Tyrosine Kinase/Adaptors
Gilteritinib hemifumarate (ASP2215 hemifumarate) 是一种高效的 ATP 竞争性 FLT3(IC50 : 0.29 nM) 和 AXL(IC50: 0.73 nM) 双重抑制剂,可用于治疗复发或难治性 FLT3 突变的 AML。
T70779 BPR1J-340

BPR1J-340 is a potent and selective FLT3 inhibitor with potential anticancer activity. BPR1J-340 was identified as a novel potent FLT3 inhibitor by biochemical kinase activity (IC50 approximately 25 nM) and cellular proliferation (GC50 approximately 5 nM) assays. BPR1J-340 inhibited the phosphorylation of FLT3 and STAT5 and triggered apoptosis in FLT3-ITD(+) AML cells. The pharmacokinetic parameters of BPR1J-340 in rats were determined. BPR1J-340 also demonstrated pronounced tumor growth inhibit...
T2243 Serdemetan

JNJ-26854165,N-[2-(1H-吲哚-3-基)乙基]-N'-(4-吡啶基)-1,4-苯二胺

Apoptosis; Mdm2; E1/E2/E3 Enzyme; p53 Apoptosis; Ubiquitination
Serdemetan (JNJ-26854165) 是一种 HDM2泛素连接酶拮抗剂,能诱导 p53野生型细胞的早期凋亡。
T10464L Atuveciclib Racemate

BAY-1143572 Racemate,阿维西利

CDK Cell Cycle/Checkpoint
Atuveciclib Racemate (BAY-1143572 Racemate) 是 Atuveciclib 的外消旋混合物。 Atuveciclib 是口服有效的 P-TEFb/CDK9高选择性抑制剂,CDK9/CycT1的 IC50为13 nM。
T4261 BPR1J-097 hydrochloride (1327167-19-0(free base))

FLT Angiogenesis; Tyrosine Kinase/Adaptors
BPR1J-097 hydrochloride (1327167-19-0(free base)) 是一种新型小分子 FLT-3抑制剂(IC50=11±7 nM),具有很好的体内抗肿瘤活性。
T62354 CDK8-IN-7

CDK8-IN-7 (compound 12) 是一种有效的、选择性的细胞周期蛋白依赖性激酶 8 (CDK8) 抑制剂 (Kd: 3.5 nM)。CDK8-IN-7 对 MOLM-13 细胞 (IC50: 5.9 μM)、OCI-AML3 细胞 (IC50: 4.8 μM)、MV4-11 细胞 (IC50: 5.4 μM)、NRK 细胞 (IC50: 16.2 μM) 和 H9c2 细胞 (IC50: 12.5-25 μM) 具有细胞毒性。CDK8-IN-7 对 AML-癌症表现出研究潜力。
T61202 TDO-IN-1

Others Others
TDO-IN-1 是一种具有口服活性、有效性和选择性的色氨酸 2,3-双加氧酶 (TDO)抑制剂 ,对吲哚胺-2,3-双加氧酶 具有抑制作用。TDO-IN-1 具有抗肿瘤活性, 能够通过逆转肿瘤组织的局部免疫耐受来发挥作用。
T39937 M-808

M-808 is a potent and efficacious covalent inhibitor, targeting the interaction between Menin and MLL. It demonstrates a high binding affinity with an IC50 value of 2.6 nM.

化合物

Kevetrin hydrochloride
Cat.No: T3184
Synonym: Thioureidobutyronitrile HCl,thioureido butyronitrile hydrochloride,4-Isothioureidobutyronitrile hydrochloride
Target: Mdm2, p53
dBRD9
Cat.No: T31221
Synonym: dBRD-9,dBRD 9
Target: PROTACs
dBRD9 HCl
Cat.No: T31221L
Synonym: dBRD9 HCl(2170679-45-3 Free base)
Target: Epigenetic Reader Domain
Sontigidomide
Cat.No: T81128
Synonym:
Target:
SR-1114
Cat.No: T81108
Synonym:
Target: PROTACs
FLT3-IN-20
Cat.No: T79596
Synonym:
Target:
Dot1L-IN-1 TFA
Cat.No: T73637
Synonym:
Target:
FY-56
Cat.No: T61768
Synonym:
Target:
eSM156
Cat.No: T24045
Synonym: eSM 156,eSM-156
Target:
DHODH-IN-16
Cat.No: T40168
Synonym:
Target: Dehydrogenase
UZH1
Cat.No: T37447
Synonym: UZH1
Target:
METTL3-IN-5
Cat.No: T81806
Synonym:
Target:
Lenalidomide-C4-NH2 hydrochloride
Cat.No: T17878
Synonym: Cereblon ligand 1 hydrochloride,E3 ligase Ligand-Linker Conjugates 32 hydrochloride
Target: Others
M‑89 MLL inhibitor
Cat.No: T69629
Synonym:
Target:
K783-0308
Cat.No: T61005
Synonym:
Target:
CDK8-IN-6
Cat.No: T62112
Synonym:
Target:
Gilteritinib hemifumarate
Cat.No: T71973
Synonym: ASP2215 hemifumarate
Target: FLT, TAM Receptor
BPR1J-340
Cat.No: T70779
Synonym:
Target:
Serdemetan
Cat.No: T2243
Synonym: JNJ-26854165,N-[2-(1H-吲哚-3-基)乙基]-N'-(4-吡啶基)-1,4-苯二胺
Target: Apoptosis, Mdm2, E1/E2/E3 Enzyme, p53
Atuveciclib Racemate
Cat.No: T10464L
Synonym: BAY-1143572 Racemate,阿维西利
Target: CDK
BPR1J-097 hydrochloride (1327167-19-0(free base))
Cat.No: T4261
Synonym:
Target: FLT
CDK8-IN-7
Cat.No: T62354
Synonym:
Target:
TDO-IN-1
Cat.No: T61202
Synonym:
Target: Others
M-808
Cat.No: T39937
Synonym:
Target:
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼